LIDOCAINE HYDROCHLORIDE VISCOUS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lidocaine Hydrochloride Viscous, and what generic alternatives are available?
Lidocaine Hydrochloride Viscous is a drug marketed by Actavis Mid Atlantic, Chartwell Molecular, Intl Medication, and Pai Holdings Pharm. and is included in four NDAs.
The generic ingredient in LIDOCAINE HYDROCHLORIDE VISCOUS is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lidocaine Hydrochloride Viscous
A generic version of LIDOCAINE HYDROCHLORIDE VISCOUS was approved as lidocaine hydrochloride by WOCKHARDT BIO AG on November 18th, 1982.
Summary for LIDOCAINE HYDROCHLORIDE VISCOUS
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Finished Product Suppliers / Packagers: | 8 |
| Raw Ingredient (Bulk) Api Vendors: | 67 |
| Clinical Trials: | 12 |
| Patent Applications: | 5 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | LIDOCAINE HYDROCHLORIDE VISCOUS at DailyMed |
Recent Clinical Trials for LIDOCAINE HYDROCHLORIDE VISCOUS
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Bispebjerg Hospital | Phase 4 |
| National Cancer Institute, Egypt | Early Phase 1 |
| Lawrence Charles Hookey | N/A |
Pharmacology for LIDOCAINE HYDROCHLORIDE VISCOUS
| Drug Class | Amide Local Anesthetic Antiarrhythmic |
| Physiological Effect | Local Anesthesia |
Anatomical Therapeutic Chemical (ATC) Classes for LIDOCAINE HYDROCHLORIDE VISCOUS
US Patents and Regulatory Information for LIDOCAINE HYDROCHLORIDE VISCOUS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Mid Atlantic | LIDOCAINE HYDROCHLORIDE VISCOUS | lidocaine hydrochloride | SOLUTION;ORAL | 086578-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Pai Holdings Pharm | LIDOCAINE HYDROCHLORIDE VISCOUS | lidocaine hydrochloride | SOLUTION;ORAL | 218138-001 | Feb 20, 2024 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Chartwell Molecular | LIDOCAINE HYDROCHLORIDE VISCOUS | lidocaine hydrochloride | SOLUTION;ORAL | 040708-001 | Feb 27, 2007 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Intl Medication | LIDOCAINE HYDROCHLORIDE VISCOUS | lidocaine hydrochloride | SOLUTION;ORAL | 086389-001 | Feb 2, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
